OLIG2 and central nervous system neoplasm: The recently described entity “CNS tumor with PLAGL amplification” (particularly PLAGL2 in infants and toddlers) also shows overlapping embryonal features with the tumors in this series [28], nonetheless with a different immune-profile—OLIG2 being mostly negative, and synaptophysin being patchy and weak.